Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
intro Tirzepatide is a dual GIP and GLP-1 receptor agonist manufactured by Eli Lilly, available under two brand names: Zepbound (FDA-approved for chronic weight management and obstructive sleep apnea) and Mounjaro (FDA-approved for type 2 diabetes)
The material here is a research-grade lyophilized peptide vial documented for in vitro laboratory work, with no patient-directed preparation, prescription pathway, or dispensing framework attached
Not all formulations contain enough B12 to fully offset absorption losses, especially at higher semaglutide doses
The Wegovy pen is injected once weekly using a prefilled device
(Ozempic and Wegovy) Semaglutide was the first GLP-1 medication for obesity to gain widespread clinical use
US$ 23.95
US$ 20.03
US$ 29.48
